tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
Holding GYRE?
Track your performance easily

Gyre Therapeutics (GYRE) Technical Analysis

799 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Gyre Therapeutics’s (GYRE) Moving Averages Convergence Divergence (MACD) indicator is -0.66, suggesting Gyre Therapeutics is a Sell.
Gyre Therapeutics’s (GYRE) 20-Day exponential moving average is 11.16, while Gyre Therapeutics’s (GYRE) share price is $11.14, making it a Sell.
Gyre Therapeutics’s (GYRE) 50-Day exponential moving average is 12.14, while Gyre Therapeutics’s (GYRE) share price is $11.14, making it a Sell.

Gyre Therapeutics (GYRE) Pivot Points

Dec 22, 2024, 07:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.36
9.96
10.31
10.91
11.26
11.86
12.21
Fibonacci
9.96
10.32
10.55
10.91
11.27
11.50
11.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gyre Therapeutics (GYRE) Moving Averages

Dec 22, 2024, 07:25 AM
Period
Simple
Exponential
MA5
10.72Buy
10.76Buy
MA10
10.48Buy
10.73Buy
MA20
10.94Buy
11.16Sell
MA50
12.89Sell
12.14Sell
MA100
12.65Sell
12.77Sell
MA200
13.49Sell
14.07Sell
Gyre Therapeutics’s (GYRE) 10-Day exponential moving average is 10.73, while Gyre Therapeutics’s (GYRE) share price is $11.14, making it a Buy.
Gyre Therapeutics’s (GYRE) 100-Day exponential moving average is 12.77, while Gyre Therapeutics’s (GYRE) share price is $11.14, making it a Sell.
Gyre Therapeutics’s (GYRE) stock price is $11.14 and Gyre Therapeutics’s (GYRE) 50-day simple moving average is 12.89, creating a Sell signal.
Gyre Therapeutics’s (GYRE) stock price is $11.14 and Gyre Therapeutics’s (GYRE) 100-day simple moving average is 12.65, creating a Sell signal.
Gyre Therapeutics’s (GYRE) stock price is $11.14 and Gyre Therapeutics’s (GYRE) 200-day simple moving average is 13.49, creating a Sell signal.

Gyre Therapeutics (GYRE) Technical Indicators

Dec 22, 2024, 07:25 AM
Name
Value
Implied Action
RSI (14)
47.54
Neutral
STOCH (9,6)
36.69
Neutral
STOCHRSI (14)
37.09
Neutral
MACD (12,26)
-0.66
Sell
ADX (14)
17.94
Buy
Williams %R
-53.00
Buy
CCI (14)
-22.10
Neutral
ATR (14)
1.14
-
Ultimate Oscillator
31.87
Neutral
ROC
-5.83
Sell
Gyre Therapeutics’s (GYRE) Relative Strength Index (RSI) is 47.54, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Trend Strength Indicator (ADX) is 17.94, creating a Buy signal.
Gyre Therapeutics’s (GYRE) Commodity Channel Index (CCI) is -22.10, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Price Rate of Change (ROC) is -5.83, creating a Sell signal.

FAQ

Is GYRE a Buy, Hold, or Sell?
Based on GYRE’s technical indicators, GYRE is a Sell.
    What is GYRE’s RSI (14)?
    GYRE’s RSI (14) is 47.54, which suggests GYRE is a Neutral.
      What is GYRE’s MACD?
      GYRE’s MACD is -0.66, which suggests GYRE is a Sell.
        What is GYRE’s 5-day moving average?
        GYRE’s 5-day moving average is 10.72, which suggests GYRE is a Buy.
          What is GYRE’s 20-day moving average?
          GYRE 20-day moving average is 10.94, which suggests GYRE is a Buy.
            What is GYRE’s 50-day moving average?
            GYRE’s 50-day moving average is 12.89, which suggests GYRE is a Sell.
              What is GYRE’s 200-day moving average?
              GYRE’s 200-day moving average is 13.49, which suggests GYRE is a Sell.
                What is GYRE’s Williams % R (14)?
                GYRE’s Williams % R (14) is -53.00, which suggests GYRE is a Buy.
                  What is GYRE’s CCI (14)?
                  GYRE’s CCI (14) is -22.10, which suggests GYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis